J.K. Cement cash flow

Latest FY26

Cash from operations: ₹1,873cr−3.4% on FY25
Capital spending: ₹2,416cr+40.5% on FY25
Free cash flow: −₹543cr₹220 cr in FY25
Cash from financing: −₹384cr₹73.8 cr in FY25

₹ crore except per share

Tap a line for its trend	Last 12Mto Sep 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Changes in working capital
Adjustments to reconcile profit — non-cash items						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	—	653	601	573	458
	—	419	451	444	302
	—	−161	−136	−123	−60.1
	—	−10.0	−9.9	−7.1	−3.5
	—	0.1	−0.6	0.0	0.0
	—	−22.4	−22.3	−24.4	−35.4
	—	−1.4	−0.1	10.5	11.4
	—	62.4	4.1	4.7	9.0
	—	−338	6.4	−203	242
	—	10.4	−225	−81.3	−48.6
	—	−66.0	58.2	−206	−125
	—	−131	−129	209	−109
	—	98.7	222	95.6	109
	—	70.3	−85.5	112	22.8
	—	50.4	157	121	121
	—	3.5	6.5	16.6	15.8
Cash from operating activities
	1,374	1,444	1,242	1,174	631
	—	638	897	940	908
	—	2,082	2,140	2,113	1,539
	—	209	200	154	162
	—	1,873	1,939	1,959	1,377
Cash from investing activities
	—	2,416	1,720	1,183	1,878
	—	18.0	21.5	5.1	8.3
	—	0.0	−8.4	0.0	0.0
	—	1,027	1,612	1,218	653
	—	1,191	1,398	954	775
	—	3.0	0.0	0.0	0.0
	—	161	163	95.1	57.0
	—	331	−152	−288	−324
	—	−1,745	−1,910	−1,636	−2,015
Cash from financing activities
	—	609	1,259	859	1,542
	—	444	560	716	411
	—	34.8	39.2	22.9	15.9
	—	400	431	420	283
	—	116	154	116	116
	—	0.3	0.0	0.2	25.0
	—	−384	73.8	−416	741
	—	−257	104	−92.3	104
	—	78.6	19.4	9.5	50.5
	—	−178	123	−82.8	154
	—	—	297	174	257
Reference items
	2,395	2,374	2,027	2,060	1,314
	15.8%	17.3%	17.1%	17.8%	13.5%
	−543	−543	220	776	−501
	—	−765	445	599	—
	−₹70.31	−₹70.31	₹28.42	₹100.39	−₹64.83
	—	1.90×	2.22×	2.48×	3.29×
	—	209	200	154	162
	—	400	431	420	283

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

JKCEMENT₹4,893.00

J.K. Cement Ltd.

· Infrastructure

₹ CrorePeersULTRACEMCO SHREECEM JKLAKSHMI DALBHARAT ACC AMBUJACEM GRASIM JSWCEMENTMcap ₹37,808 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/09/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation	458.2	572.6	601.5	653.0	—
+ Finance Costs	301.9	443.5	450.7	418.6	—
+ Interest Income	-60.1	-123.4	-136.3	-161.0	—
+ Fair Value (Gains) / Losses	-3.5	-7.1	-9.9	-10.0	—
+ Undistributed Profits of Associates	0.0	0.0	-0.6	0.1	—
+ Other Non-cash Items	-35.4	-24.4	-22.3	-22.4	—
+ Other — Cash Effects are Investing / Financing	11.4	10.5	-0.1	-1.4	—
+ Other Reconciling Items	9.0	4.7	4.1	62.4	—
Changes in Working Capital
+ Inventories	241.6	-202.7	6.4	-337.7	—
+ Trade Receivables — Current	-48.6	-81.3	-225.4	10.4	—
+ Other Financial Assets — Non-current	-125.5	-206.4	58.2	-66.0	—
+ Other Current Assets	-109.3	208.5	-129.4	-130.5	—
+ Trade Payables — Current	109.0	95.6	221.8	98.7	—
+ Other Financial Liabilities — Current	22.8	111.8	-85.5	70.3	—
+ Other Current Liabilities	120.6	120.9	156.7	50.4	—
+ Provisions — Current	15.8	16.6	6.5	3.5	—
Cash from Operating Activities
Profit Before Tax (per I/S)	631.3	1,173.6	1,242.4	1,443.7	1,373.6
+ Total Adjustments (incl. Working Capital)	908.0	939.6	897.4	638.1	—
Cash from Operations (pre-tax)	1,539.3	2,113.2	2,139.8	2,081.8	—
+ Income Taxes Paid	162.2	154.2	200.4	208.8	—
Cash from Operating Activities	1,377.1	1,959.1	1,939.4	1,873.0	—
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)	1,878.0	1,183.3	1,719.8	2,416.2	—
+ Disp of Fixed Assets	8.3	5.1	21.5	18.0	—
+ Disp of Biological Assets	0.0	0.0	-8.4	0.0	—
+ Purchase of Investments (Equity / Debt)	652.7	1,217.8	1,611.6	1,027.1	—
+ Sale of Investments (Equity / Debt)	775.0	953.5	1,397.6	1,190.8	—
+ Loans & Advances Made	0.0	0.0	0.0	3.0	—
+ Interest Received — Investing	57.0	95.1	162.7	160.7	—
+ Other Inflows / (Outflows) — Investing	-324.5	-288.4	-151.6	331.4	—
Cash from Investing Activities	-2,014.8	-1,635.8	-1,909.7	-1,745.5	—
Cash from Financing Activities
+ Proceeds from Borrowings	1,542.2	859.1	1,259.0	609.0	—
+ Repayment of Borrowings	411.1	716.1	560.4	443.5	—
+ Payment of Lease Liabilities	15.9	22.9	39.2	34.8	—
+ Interest Paid	282.9	420.0	431.2	399.6	—
+ Dividends Paid	115.9	115.8	154.4	115.9	—
+ Other Inflows / (Outflows) — Financing	25.0	0.2	0.0	0.3	—
Cash from Financing Activities	741.3	-415.6	73.8	-384.4	—
Net Changes in Cash (pre-FX)	103.6	-92.3	103.5	-256.9	—
+ Effect of FX Rate Changes on Cash	50.5	9.5	19.4	78.6	—
Net Changes in Cash	154.1	-82.8	122.9	-178.4	—
Closing Cash	257.1	174.4	297.3	—	—
Reference Items
EBITDA	1,314.3	2,059.8	2,027.1	2,374.3	2,395.2
EBITDA Margin %	13.52	17.82	17.06	17.30	15.85
Free Cash Flow (CFO − Capex)	-500.9	775.8	219.6	-543.3	-543.3
Free Cash Flow to Equity	—	599.2	445.4	-764.7	—
Free Cash Flow per Basic Share	-64.83	100.39	28.42	-70.31	-70.31
Cash Flow to Net Income	3.29	2.48	2.22	1.90	—
Cash Paid for Taxes	162.2	154.2	200.4	208.8	—
Cash Paid for Interest	282.9	420.0	431.2	399.6	—

As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.